Back to News
Market Impact: 0.4
Tempus AI Is Ripping 30% Higher This Week After Morgan Stanley Boosts Revenue Outlook
Source: 247wallst.com
Artificial IntelligenceHealthcare & BiotechAnalyst InsightsCompany Fundamentals
Tempus AI shares rallied 29% during the week after Morgan Stanley's September 15 remarks highlighted new reimbursement-driven revenue upside for the AI-powered diagnostics company. The commentary points to improving monetization potential from diagnostic reimbursement, providing a positive near-term catalyst for TEM.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment
MS0.12
TEM0.82
More News
- Crusoe raises $3.9B to build massive data centers and small modular “AI factories”
- Warsh says AI’s hyperscalers are part of why your borrowing costs are rising: ‘The competition for capital is real’
- Stocks stage a comeback after Fed-induced declines — plus, what's ailing Boeing
- The Under-the-Radar Stock Big Money Is Quietly Buying Up
- Real-Economy Corporate Events Investors Should Watch This Month
- Morgan Stanley cuts Peloton stock rating on growth concerns